KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Shares Outstanding (Diluted Average) (2021 - 2026)

Staar Surgical (STAA) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $49.6 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 0.9% year-over-year to $49.6 million, compared with a TTM value of $49.6 million through Jan 2026, up 0.9%, and an annual FY2026 reading of $49.6 million, up 0.9% over the prior year.
  • Shares Outstanding (Diluted Average) was $49.6 million for Q1 2026 at Staar Surgical, down from $50.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $50.5 million in Q3 2025 and bottomed at $48.9 million in Q1 2024.
  • Average Shares Outstanding (Diluted Average) over 5 years is $49.5 million, with a median of $49.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) fell 1.2% in 2024, then rose 1.88% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $49.4 million in 2022, then grew by 0.1% to $49.4 million in 2023, then dropped by 0.61% to $49.1 million in 2024, then rose by 2.9% to $50.5 million in 2025, then fell by 1.94% to $49.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for STAA at $49.6 million in Q1 2026, $50.5 million in Q3 2025, and $49.5 million in Q2 2025.